KELLY ARMBRUSTER: Open Payments
NPI 1336664689 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,501 in 60 payments from 21 companies in 2025. Trend: 2023 $716 · 2024 $1,273 · 2025 $1,501
Food & beverage: $1,321Education: $180
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $161 |
| Janssen Biotech, Inc. | 3 | $152 |
| ABBVIE INC. | 5 | $106 |
| SEAGEN INC. | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $96 |
| Daiichi Sankyo Inc. | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Merck Sharp & Dohme LLC | 4 | $82 |
| Eisai Inc. | 4 | $81 |
| Legend Biotech USA Inc. | 3 | $78 |
Products named: RYBREVANT, Enhertu, VENCLEXTA, KISQALI, OPDIVO, KEYTRUDA, Lenvima, CARVYKTI.
Industry payments across VA — which companies pay providers there.
